Recruiting Pancreatitis Studies in Birmingham
Safety and Tolerability of Pirfenidone in Acute Pancreatitis
The goal of the current pilot clinical trial is to evaluate the safety and tolerability of pirfenidone in patients with predicted moderately severe and severe acute pancreatitis. Pirfenidone is curren...
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
This clinical will evaluate the safety, tolerability and early efficacy of pirenidone in patients with recurrent acute pancreatitis....
About Pancreatitis Clinical Trials in Birmingham
Pancreatitis is inflammation of the pancreas that can be acute or chronic, often caused by gallstones or heavy alcohol use. Chronic pancreatitis leads to progressive damage and impaired function. Treatment includes pain management, enzyme replacement, dietary changes, and treating underlying causes.
There are currently 2 pancreatitis clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 120 participants. Research is being sponsored by University of Alabama at Birmingham. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pancreatitis Clinical Trials in Birmingham — FAQ
Are there pancreatitis clinical trials in Birmingham?
Yes, there are 2 pancreatitis clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What pancreatitis treatments are being tested?
The 2 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatitis.
Data updated March 2, 2026 from ClinicalTrials.gov